Implementation of a Prehospital Air Medical Thawed Plasma Program: Is It Even Feasible?

Peter D. Adams,Kayla Warren,Frank X. Guyette,Mark H. Yazer,Joshua D. Brown,Brian Daily,Richard S. Miller,Brain G. Harbrecht,Jeffrey A. Claridge,Herb A. Phelan,William R. Witham,A. Putnam,Brian S. Zuckerbraun,Matthew D. Neal,Jason L. Sperry

Implementation of a Prehospital Air Medical Thawed Plasma Program: Is It Even Feasible?

2019

Peter D. Adams
Kayla Warren
Frank X. Guyette
Mark H. Yazer
Joshua D. Brown
Brian Daily
Richard S. Miller
Brain G. Harbrecht
Jeffrey A. Claridge
Herb A. Phelan
William R. Witham
A. Putnam
Brian S. Zuckerbraun
Matthew D. Neal
Jason L. Sperry

AbstractIntroductionThe PAMPer trial demonstrated a 30-day survival benefit among hypotensive trauma patients treated with prehospital plasma during air medical transport. We characterized resources, costs and feasibility of air medical prehospital plasma program implementation.MethodsWe performed a

Keywords:

Emergency medicine
Intensive care medicine
Medicine
survival benefit

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations